• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

IMS Health

Anonymous board for IMS Health.
Replies
75
Views
42K
anonymous
Replies
1
Views
3K
anonymous
Replies
3
Views
7K
anonymous
Replies
1
Views
4K
anonymous
Replies
6
Views
7K
Anonymous
Replies
4
Views
9K
Anonymous
Replies
1
Views
4K
Anonymous
Replies
0
Views
4K
Anonymous
Replies
1
Views
4K
Anonymous
Replies
3
Views
4K
Anonymous
Replies
1
Views
4K
Anonymous
Replies
23
Views
13K
Anonymous
Replies
3
Views
3K
Anonymous
Replies
2
Views
4K
Anonymous
Replies
9
Views
10K
Anonymous